Midecamycin is a 16-membered macrolide antibiotic produced by Streptomyces mycarofaciens, used to treat bacterial infections in the respiratory tract, skin, oral cavity, and genitourinary system by inhibiting… Read more
Midecamycin is a 16-membered macrolide antibiotic produced by Streptomyces mycarofaciens, used to treat bacterial infections in the respiratory tract, skin, oral cavity, and genitourinary system by inhibiting protein synthesis through binding to the 50S ribosomal subunit. This category provides access to high-quality reference standards for Midecamycin, including related impurities such as 3-Epi-3-O-Propionylleucomycin A7. These compounds are essential for pharmaceutical laboratories conducting rigorous impurity profiling and method validation to ensure drug safety and efficacy. By utilizing these pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds, analytical chemists can accurately identify and quantify degradation products and metabolites during routine quality control procedures. These materials serve as the foundational benchmarks required to maintain strict adherence to regulatory standards in the analysis and characterization of this antibiotic throughout its manufacturing and stability testing lifecycles.